<p>Ischemic stroke, and obese-insulin resistance are common pathological conditions that lead to brain injury, resulting in neurodegeneration, brain atrophy, and cognitive dysfunction. Rare sugars, which are scarce monosaccharide in nature, have been investigated as a potential treatment for these adverse conditions. However, the beneficial effects of rare sugars on the brain have never been summarized. Therefore, this article comprehensively summarizes and discusses the benefits of rare sugars on the brain under physiological condition, ischemic stroke, and obese-insulin resistance. The potential mechanisms mediating these benefits of rare sugars are also described. Any contradictory findings are also included. This article adds weight to the impetus for further investigations into the applications of rare sugars as a novel therapeutic paradigm in clinical application.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

The beneficial effects of D-allose and D-allulose on the brain under ischemic stroke and obese-insulin resistant conditions: evidence from in vitro to clinical studies

  • Yanmei Huang,
  • Chanisa Thonusin,
  • Masaaki Tokuda,
  • Nipon Chattipakorn,
  • Siriporn C. Chattipakorn

摘要

Ischemic stroke, and obese-insulin resistance are common pathological conditions that lead to brain injury, resulting in neurodegeneration, brain atrophy, and cognitive dysfunction. Rare sugars, which are scarce monosaccharide in nature, have been investigated as a potential treatment for these adverse conditions. However, the beneficial effects of rare sugars on the brain have never been summarized. Therefore, this article comprehensively summarizes and discusses the benefits of rare sugars on the brain under physiological condition, ischemic stroke, and obese-insulin resistance. The potential mechanisms mediating these benefits of rare sugars are also described. Any contradictory findings are also included. This article adds weight to the impetus for further investigations into the applications of rare sugars as a novel therapeutic paradigm in clinical application.